Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors-Reference-Cited by-同舟云学术

Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors

Published:2022-06 Issue:11 Volume:15 Page:1167-1175
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Figtree Gemma A.,Redfors Bjorn,Kozor Rebecca,Vernon Stephen T.,Grieve Stuart M.,Mazhar Jawad,Thiele Holger,Patel Manesh R.,Udelson James E.,Selker Harry P.,Ohman E. Magnus,Maehara Akiko,Karmpaliotis Dmitri,Eitel Ingo,Granger Christopher B.,Ben-Yehuda Ori,Stone Gregg W.,Kosmidou Ioanna

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

2. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease;Jellinger;Endocr Pract,2017

3. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective;Mahmood;Lancet,2014

4. Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors;Vernon;Eur J Prev Cardiol,2017

5. ST-segment-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes?;Vernon;J Am Heart Assoc,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and in-hospital outcomes of female patients presenting with ST-segment-elevation myocardial infarction without standard modifiable cardiovascular risk factors;Current Problems in Cardiology;2024-12

2. Clinical outcomes and coronary artery lesion characteristics of young patients with ST elevation myocardial infarction and no standard modifiable risk factors;Catheterization and Cardiovascular Interventions;2024-09-09

3. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17

4. Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention;Open Heart;2024-06

5. Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry;Journal of the American Heart Association;2024-05-21